Revolution Medicines, Inc. logo

Revolution Medicines, Inc.

NASDAQ:RVMD

Overview | Financials
Company Name Revolution Medicines, Inc.
Symbol RVMD
Currency USD
Price 59.1
Market Cap 9,872,004,900
Dividend Yield 0%
52-week-range 18.79 - 60.53
Industry Biotechnology
Sector Healthcare
CEO Dr. Mark A. Goldsmith Ph.D.
Website https://www.revmed.com

An error occurred while fetching data.

About Revolution Medicines, Inc.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also

Related Stocks

Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc.

ZNTL

3.81 USD

Cronos Group Inc. logo

Cronos Group Inc.

CRON

2.06 USD

Atrion Corporation logo

Atrion Corporation

ATRI

459.92 USD

Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc.

MDGL

354.85 USD

Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

CLDX

26.47 USD

Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc.

PACB

2.45 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

3.67 USD

Financials

Numbers are in millions USD

Numbers are in millions USD